Article

Biosimilar Payment Models Highlight Week in Specialty Pharmacy

Author(s):

Davy James, Managing Editor

Top news of the week on Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/biosimilar-payment-models-highlight-week-in-specia" target="_blank">View the story "Biosimilar Payment Models Highlight Week in Specialty Pharmacy" on Storify</a>]

Related Videos
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards
October is American Pharmacists Month.
smiling indian male doctor or pharmacist in white coat with stethoscope and clipboard over drugstore background
Efficient healthcare supply chain management ensures timely delivery of medical supplies and medications
Pharmacy Deserts, Data, Analytics | Image Credit: Nikish H/peopleimages.com - stock.adobe.com
Group of doctors and nurses standing together in different poses.
Related Content
FDA Issues Complete Response Letter for Much-Anticipated GLP-2 Analog
December 21st 2024

FDA Issues Complete Response Letter for Much-Anticipated GLP-2 Analog

Aislinn Antrim, Assistant Managing Editor
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Associate Editor
FDA Approves Expanded Use for Trikafta in Cystic Fibrosis
December 20th 2024

FDA Approves Expanded Use for Trikafta in Cystic Fibrosis

Aislinn Antrim, Assistant Managing Editor
Season 3 - Public Health Matters: A Look at Wearable Technology, AI-Assisted Innovations
January 25th 2024

Season 3 - Public Health Matters: A Look at Wearable Technology, AI-Assisted Innovations

Mounjaro tirzepatide GLP-1 receptor agonist vial | Image Credit: © Cynthia - stock.adobe.com
December 20th 2024

FDA Affirms Decision on Tirzepatide Shortage Resolved, Sets Transition Period for Compounding

Alexandra Gerlach, Associate Editor
FDA Approval, Familial Chyomicronemia Syndrome | Image Credit: Tyler Olson | stock.adobe.com
December 20th 2024

FDA Approves Olezarsen as Adjunct to Diet for Familial Chylomicronemia Syndrome

Ashley Gallagher, Associate Editor